Nouscom will present at the NeoAg Summit 2018
The 3rd NeoAg Summit is the leading end-to-end industry- focused meeting dedicated to advancing neoantigen-based cancer vaccines and cell therapies. Download the full program of NeoAg Summit 2018.
Nouscom will present at the World Vaccine Congress Europe 2018
Find out the full program here: https://www.terrapinn.com/conference/world-vaccine-congress-europe/agenda.stm
Nouscom will present at Biocapital Europe
Find out the full program here: http://www.biocapitaleurope.com
NousCom presents at Agenda Sachs Forum
Full program: http://www.sachsforum.com/uploads/5/1/9/6/51964431/17thbef-finalagenda.pdf
NousCom presents at 3rd CRI-CIMT-EATI-AACR INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE
Mainz, Germany Abstract Title: Great Apes Adenovirus neoantigens vaccine synergizes with immunomodulators in mouse models of cancer.
NousCom presents at 3rd Annual Immuno-Oncology BD&L and Investment Forum
EMBL Heidelberg, Germany Full program: https://am.asco.org
NousCom presents at Agenda Sachs Forum
NousCom will present at the 17th Biotech In Europe Forum for Global Partnering and Investment. The forum wiil take place on 26th-27th September at the Congress Center Basel (switzerland). Feel [...]
NousCom presents at EMBL-Cancer Core Europe Conference: Cancer Immunotherapy
EMBL Heidelberg, Germany Abstract Title: Personalized cancer vaccine based on ChAd vaccine improves over the anti-PD1 activity.
NousCom presents at the 1ST Meeting of the European Hereditary Tumour Group (EHTG)
Palma, Mallorca Abstract Title: Development of cell based immunity based on multiple epitopes: Lessons from prophylactic genetic vaccines.
